This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Hanlim Pharmaceutical Co., Ltd., Catholic University Academic Cooperation Foundation, Catholic University Industry Academic Cooperation Foundation. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 10 
1 out of 1 
1 out of 54 Years Active: 2014-2016
Title: A Closer Look at Inventor Eun-Young Kwak
Introduction
Eun-Young Kwak is an innovative inventor based in Seoul, South Korea, recognized for his significant contributions to the field of pharmaceuticals. His work primarily focuses on developing effective treatments for osteoarthritis and rheumatoid arthritis, showcasing his dedication to improving healthcare through scientific advancements.
Latest Patents
Eun-Young Kwak holds two notable patents. The first patent pertains to a pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient. This invention outlines a method for preventing or treating osteoarthritis through the administration of rebamipide in a suitable form, including oral solid dosage forms like tablets or capsules. The composition is designed for effective dosage ranging from 0.5 to 50 mg/kg.
The second patent is a pharmaceutical composition aimed at preventing or treating rheumatoid arthritis, again featuring rebamipide as the core active ingredient. Similar to his previous invention, this composition also emphasizes oral administration in various forms and dosage ranges to ensure optimal therapeutic effects.
Career Highlights
Throughout his career, Eun-Young Kwak has been associated with prominent organizations, including Hanlim Pharmaceutical Co., Ltd. and the Catholic University Academic Cooperation Foundation. His tenure at these institutions has facilitated his research and development efforts, allowing him to make substantial breakthroughs in pharmaceutical science.
Collaborations
Eun-Young Kwak has collaborated with several professionals in the field, including colleagues Jun-Ki Min and Mi-La Cho. Their joint efforts have fostered a productive research environment, paving the way for innovative solutions in treating debilitating diseases.
Conclusion
Eun-Young Kwak's inventiveness and dedication to advancing pharmaceutical compositions reflect his influential role in improving patient care. With his innovative patents targeting osteoarthritis and rheumatoid arthritis, he exemplifies the spirit of innovation that drives progress in the medical field. His contributions continue to inspire future research and development efforts in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile